Certified by Founder Lodge
Resalis Therapeutics
Italy - Turin, Piedmont
START UP
1 Disclosed Funding Rounds $10,952,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease.
The company is applying its unique
Date | Round | Raised | Participating Investors |
---|---|---|---|
January, 08 ,2024 | Pre Series A | $10,952,000 |